{
    "Rank": 363,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT05877404",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "IRB00097221"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "WFBCCC 99323",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "Wake Forest Baptist Comprehensive Cancer Center"
                        },
                        {
                            "SecondaryId": "P30CA012197",
                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/P30CA012197"
                        },
                        {
                            "SecondaryId": "NCI-2023-05554",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "CTRP"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Wake Forest University Health Sciences",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer",
                "OfficialTitle": "Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "August 2023",
                "OverallStatus": "Not yet recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "September 2023",
                    "StartDateType": "Anticipated"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "January 2024",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "January 2024",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "May 17, 2023",
                "StudyFirstSubmitQCDate": "May 17, 2023",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 26, 2023",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "August 29, 2023",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "August 31, 2023",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Wake Forest University Health Sciences",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "National Cancer Institute (NCI)",
                            "CollaboratorClass": "NIH"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.",
                "DetailedDescription": "Primary Objective: Proportion of physicians reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients.\n\nSecondary Objectives:\n\nExplore the use of informed consent in tumor genetic testing in endometrial cancer\nExplore clinician confidence in utilizing tumor genetic testing to guide treatment decisions.\nExplore the impact of recent publications regarding immunotherapy on the use of tumor genetic testing in endometrial cancer."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Endometrial Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Genetic testing"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Other"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "360",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Gynecologic Oncologists",
                            "ArmGroupDescription": "Gynecologic Oncologists and gynecologic oncology fellows-in-training from around the world, who are members of the Society of Gynecologic Oncology (SGO).",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: Surveys"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Surveys",
                            "InterventionDescription": "Survey on practice patterns surrounding tumor genetic testing in endometrial cancer.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Gynecologic Oncologists"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Percentage of providers reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients",
                            "PrimaryOutcomeDescription": "The primary outcome is to estimate the percentage of providers who report the use of different tumor testing strategies. Investigators will calculate the frequencies of responses to each testing strategy and then compare the percentage of physicians who choose different strategies, using a chi-square or Fisher's exact test.",
                            "PrimaryOutcomeTimeFrame": "4 months"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Frequency of providers using different strategies of informed consent in tumor genetic testing in endometrial cancer",
                            "SecondaryOutcomeDescription": "Investigators will calculate the number of frequencies of different tumor testing informed consent strategies among physicians.",
                            "SecondaryOutcomeTimeFrame": "4 months"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Number of providers reporting confidence in utilizing tumor genetic testing to guide treatment decisions",
                            "SecondaryOutcomeDescription": "Investigators will calculate the number of providers who are very confident, moderately confident, a little confident or not at all confident in their ability to explain tumor testing strategies and results.",
                            "SecondaryOutcomeTimeFrame": "4 months"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Number of providers who change their counseling or testing strategies for endometrial cancer",
                            "SecondaryOutcomeDescription": "Investigators will compare the number of providers who have changed their counseling or testing strategy based on their familiarity with recent publications regarding immune-checkpoint inhibitors in advanced and recurrent endometrial cancer using a chi-square or Fisher's exact test.",
                            "SecondaryOutcomeTimeFrame": "4 months"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nMember of the Society of Gynecologic Oncology\nGynecologic Oncologist or Gynecologic Oncology Fellow-in-Training",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "All",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Gynecologic Oncologists and gynecologic oncology fellows-in-training from around the world, who are members of the Society of Gynecologic Oncology (SGO).",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Study Coordinator",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "336-713-0031",
                            "CentralContactEMail": "mnjenkin@wakehealth.edu"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Kathryn Weaver, PhD, MPH",
                            "OverallOfficialAffiliation": "Wake Forest Baptist Comprehensive Cancer Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Wake Forest Baptist Comprehensive Cancer Center",
                            "LocationCity": "Winston-Salem",
                            "LocationState": "North Carolina",
                            "LocationZip": "27157",
                            "LocationCountry": "United States",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Study Coodinator",
                                        "LocationContactRole": "Contact",
                                        "LocationContactPhone": "336-713-0031",
                                        "LocationContactEMail": "mnjenkin@wakehealth.edu"
                                    },
                                    {
                                        "LocationContactName": "Kathryn Weaver, PhD, MPH",
                                        "LocationContactRole": "Principal Investigator"
                                    }
                                ]
                            }
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "No"
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000016889",
                            "ConditionMeshTerm": "Endometrial Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000014594",
                            "ConditionAncestorTerm": "Uterine Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000005833",
                            "ConditionAncestorTerm": "Genital Neoplasms, Female"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000014591",
                            "ConditionAncestorTerm": "Uterine Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005831",
                            "ConditionAncestorTerm": "Genital Diseases, Female"
                        },
                        {
                            "ConditionAncestorId": "D000052776",
                            "ConditionAncestorTerm": "Female Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005261",
                            "ConditionAncestorTerm": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M18925",
                            "ConditionBrowseLeafName": "Endometrial Neoplasms",
                            "ConditionBrowseLeafAsFound": "Endometrial Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M17032",
                            "ConditionBrowseLeafName": "Uterine Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8635",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17029",
                            "ConditionBrowseLeafName": "Uterine Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8633",
                            "ConditionBrowseLeafName": "Genital Diseases, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26783",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13817",
                            "ConditionBrowseLeafName": "Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8089",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases and Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}